FDA Clears VNS Device for Paroxysmal Hemicrania, Hemicrania Continua
Patients treated with gammaCore experienced clinically meaningful benefits.
Migraine and Headache
Meloxicam/Rizatriptan Combo Under Review for Migraine Treatment
The application is supported by data from the phase 3 MOMENTUM and INTERCEPT trials.
Trudhesa Nasal Spray Approved for Acute Treatment of Migraine
The approval is supported by data from the phase 3 STOP 301 study, which evaluated the safety and tolerability of Trudhesa in 354 adults with migraine.
Study Compares Remote Electrical Neuromodulation to Migraine Meds in Adolescents
Nerivio is a wireless remote electrical neuromodulation device approved for the acute treatment of episodic or chronic migraine in patients 12 years of age and older.
Complex Interaction Between Migraine Symptoms and Gastrointestinal Comorbidities
Researchers searched publication databases for studies of the gut-brain connection, migraine, and gastric disorders.
Nurtec ODT Approval Expanded to Include Migraine Prevention
Rimegepant is an oral calcitonin gene-related peptide receptor antagonist.
Atorvastatin With Sodium Valproate Can Reduce Migraine Attacks and Pain Severity
Atorvastatin may have augmentative effects with sodium valproate in the reduction of migraines with aura.
Novel Class of Preventive Treatments for Migraine
Anti-calcitonin gene-related peptide monoclonal antibodies are the first approved pharmacologic treatments developed explicitly for the prevention of migraine.
The Effects of Puberty and Menstrual Cycle on Migraine in Girls
Migraine attacks were more frequent in post-pubertal compared to pre-pubertal girls, with no observed difference in headache characteristics between the groups.
New Findings on Timing of Migraines After Poor Sleep
Researchers found that a poor night’s sleep may increase risk for migraine the following day, rather than the next morning.
- Loading...
Loading...
Next post in News
Loading... 
Loading...